The University of Saskatchewan (U of S) Vaccine and Infectious Disease Organization (VIDO) has been awarded a major research contract that could position the organization as a global player in the industry.
“It all really speaks to the quality of the scientists that are doing the work here,” said Volker Gerdts, VIDO CEO.
“We have some of the world’s best infrastructure here at VIDO. Now it’s good to see that it’s being recognized by an international organization — an important international organization like the NIH — recognizing that VIDO is a global player in infectious disease research.”
The National Institutes of Health (NIH) awarded the indefinite delivery, or indefinite quantity, contract under its pre-clinical models of infectious disease program. VIDO was the only Canadian organization selected for the program and one of only four organizations worldwide.
Gerdts said NIH is the largest funder for any bio-technical research or biomedical research …